Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuning Le
John Heymach

Showing results (1-10 of 239) with videos related to

Pageof 24
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2022
In ResponseXiuning Le, John Heymach
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 29, 2023
Resistance to EGFR Inhibitors: Fitness, Competition, and DiversityXiuning Le
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 30, 2021
Heterogeneity in MET-Aberrant NSCLCXiuning Le
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2024
Partners in Crime: Co-Occurring Genetic Alterations in EGFR-Mutant NSCLCXiuning Le
Heliyon|July 3, 2023
AI in drug discovery and its clinical relevanceRizwan Qureshi, Muhammad Irfan, Taimoor Muzaffar Gondal, et al.
The Lancet. Oncology|January 15, 2026
Precision oncology in resected EGFR-mutant NSCLCAntonio Passaro, Xiuning Le
The Oncologist|January 5, 2021
New Verse for a Familiar Song: Small Molecule Inhibitors for MET exon 14 Skipping Non-Small Cell Lung CancerXiuning Le, John V Heymach
Expert Opinion on Drug Discovery|March 20, 2013
Potential of zebrafish for anticancer drug screeningLeonard I Zon, Xiuning Le
Annals of Translational Medicine|July 20, 2018
Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determinedXiuning Le, Ehab Y Hanna
Targeted Oncology|May 26, 2026
HER2-Mutant Non-Small Cell Lung Cancer Podcast: Knowledge Is PowerVivek Subbiah, Martin Dietrich, Xiuning Le
Pageof 24

Showing results (1-10 of 239) with videos related to

Sort By:
Pageof 24
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2022
In ResponseXiuning Le, John Heymach
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 29, 2023
Resistance to EGFR Inhibitors: Fitness, Competition, and DiversityXiuning Le
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 30, 2021
Heterogeneity in MET-Aberrant NSCLCXiuning Le
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2024
Partners in Crime: Co-Occurring Genetic Alterations in EGFR-Mutant NSCLCXiuning Le
Heliyon|July 3, 2023
AI in drug discovery and its clinical relevanceRizwan Qureshi, Muhammad Irfan, Taimoor Muzaffar Gondal, et al.
The Lancet. Oncology|January 15, 2026
Precision oncology in resected EGFR-mutant NSCLCAntonio Passaro, Xiuning Le
The Oncologist|January 5, 2021
New Verse for a Familiar Song: Small Molecule Inhibitors for MET exon 14 Skipping Non-Small Cell Lung CancerXiuning Le, John V Heymach
Expert Opinion on Drug Discovery|March 20, 2013
Potential of zebrafish for anticancer drug screeningLeonard I Zon, Xiuning Le
Annals of Translational Medicine|July 20, 2018
Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determinedXiuning Le, Ehab Y Hanna
Targeted Oncology|May 26, 2026
HER2-Mutant Non-Small Cell Lung Cancer Podcast: Knowledge Is PowerVivek Subbiah, Martin Dietrich, Xiuning Le
Pageof 24